newsfilter
← Latest News
PR Newswire·

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

I-Mab (NASDAQ: IMAB) (the "Company"), a US-based, global biotech company, exclusively focused on the development of highly differentiated...